{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:28:47Z","timestamp":1790166527409,"version":"4.1.0"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2038,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1111\/j.1601-6343.2009.01472.x","type":"journal-article","created":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T10:12:44Z","timestamp":1262945564000},"page":"1-10","source":"Crossref","is-referenced-by-count":40,"title":["Bisphosphonates treatment and orthodontic considerations"],"prefix":"10.1111","volume":"13","author":[{"given":"AA","family":"Ghoneima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ES","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SL","family":"Zunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LJ","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB1","first-page":"759","article-title":"Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two Case Reports","volume":"31","author":"Sarathy","year":"2005","journal-title":"JOE"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/154405910708601101","article-title":"Osteonecrosis of the jaws and bisphosphonates therapy","volume":"86","author":"Ruggiero","year":"2007","journal-title":"J Dent Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB3","first-page":"76","article-title":"The top 200 brand-name drugs in 2003","volume":"148","year":"2004","unstructured":"3.The top 200 brand-name drugs in 2003. Drug Topics 2004;148:76.","journal-title":"Drug Topics"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB4","unstructured":"4.The top 200 brand-name drugs by units in 2006. Available at: http:\/\/www.drugtopics.modernmedicine.com (Last accessed 9 April 2009)."},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB5","first-page":"2226","volume-title":"Harrison\u00e2\u0080\u0099s Principles of Internal Medicine","author":"Lindsay","year":"2001"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB6","first-page":"1558","article-title":"Practical guidelines: ACOG releases guidelines for clinical management of osteoporosis","volume":"69","author":"Neff","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/0003-4819-126-6-199703150-00007","article-title":"The osteoporosis revolution","volume":"126","author":"Raisz","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB8","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology Clinical Practice Guidelines: the role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB9","first-page":"A531","article-title":"Long-term reduction of skeletal complications in breast cancer patients with osteolytic bone metastases receiving hormone therapy by monthly 90\u00e2\u0080\u0083mg pamidronate infusions","volume":"16","author":"Lipton","year":"1997","journal-title":"Proc Ann Meet Am Soc Clin Oncol"},{"issue":"suppl 2","key":"10.1111\/j.1601-6343.2009.01472.x-BIB10","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.3816\/CBC.2005.s.005","article-title":"Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer","volume":"5","author":"Gralow","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/edrv.23.1.0453","article-title":"Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint","volume":"23","author":"Marcus","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB12","unstructured":"12. Brixen K . Bisphosphonates as a potential treatment for osteogenesis imperfecta. Proceedings of the OIFE meeting, September 25-26, 1998. Vingsted, Denmark. Available at: http:\/\/www.brandx.net\/markgash\/bispho.html."},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMp038103","article-title":"Do bisphosphonates make children\u00e2\u0080\u0099s bones better or brittle?","volume":"349","author":"Marini","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB14","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"issue":"Suppl","key":"10.1111\/j.1601-6343.2009.01472.x-BIB15","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","volume":"20","author":"Roelofs","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB16","first-page":"538","article-title":"Effects of bisphosphonates on matrix mineralization","volume":"2","author":"Boivin","year":"2002","journal-title":"J Musculoskel Neuron Interact"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","article-title":"Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis","volume":"14","author":"Sarin","year":"2008","journal-title":"Oral Dis"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB18","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1054\/bjoc.2000.1679","article-title":"Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line","volume":"84","author":"Mackie","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/erc.0.0110207","article-title":"The role of bisphosphonates in breast and prostate cancers","volume":"11","author":"Brown","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB21","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00044011-200525020-00003","article-title":"Pharmacokinetic considerations in determining the terminal elimination half lives of bisphosphonates","volume":"25","author":"Lasseter","year":"2005","journal-title":"Clin Drug Invest"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB23","first-page":"40","volume-title":"Bisphosphonates in Bone Disease: From the Laboratory to the Patient","author":"Fleisch","year":"2000"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB24","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1345\/aph.1E357","article-title":"Discovery, clinical development, and therapeutic uses of bisphosphonate","volume":"39","author":"Licata","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB25","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteonecrosis (bisphossy jaw): is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5694\/j.1326-5377.2005.tb06970.x","article-title":"Bisphosphonates and osteonecrosis: analogy to phossy jaw","volume":"183","author":"Donoghue","year":"2005","journal-title":"Med J Aust"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB28","first-page":"74","article-title":"Failure of osteointergrated dental implants after diphosphonate therapy for osteoporosis: a case report","volume":"10","author":"Starck","year":"1995","journal-title":"Int J Maxillofac Implants"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB31","unstructured":"31.FDA Patient Safety News. Show #34, December 2004. Caution on osteonecrosis with bisphosphonates. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/psn."},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB32","unstructured":"32.Novartis Pharmaceuticals Corporation. Important drug precaution for dental health professionals with patients being treated for cancer [letter to dentists]. Available at: http:\/\/www.fda.gov\/medwatch\/safety\/2005\/zometa_deardentite_5\u00e2\u0080\u00935\u00e2\u0080\u009305.pdf."},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-0714.2005.00351.x","article-title":"Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates: a four case report","volume":"34","author":"Merigo","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zolendronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB35","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB36","first-page":"1674","article-title":"Updated recommendations for managing the care of patients receiving oral bisphosphonates therapy. An advisory statement from the American Dental Association Council on Scientific Affairs","volume":"139","author":"Edwards","year":"2008","journal-title":"JADA"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajodo.2006.11.002","article-title":"Orthodontic treatment of patients using bisphosphonates: a report of 2 cases","volume":"131","author":"Rinchuse","year":"2007","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0889-5406(94)70048-6","article-title":"Anchorage and retentive effects of a bisphosphonates (AHBuBP) on tooth movements in rats","volume":"106","author":"Igarashi","year":"1994","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF02547219","article-title":"Effect of ethane-l-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats","volume":"11","author":"Schenk","year":"1973","journal-title":"Calcif Tissue Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02546397","article-title":"The alteration of osteoclast morphology by diphosphonates in bone organ culture","volume":"20","author":"Rowe","year":"1976","journal-title":"Calcif Tissue Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02408548","article-title":"Influence of a diphosphonate on the cellular aspect of young bone tissue","volume":"32","author":"Plasmans","year":"1980","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB43","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI114459","article-title":"Bisphosphonates directly inhibit the bone resorption","volume":"85","author":"Carano","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00441-007-0499-y","article-title":"Effects of alendronate on tooth eruption and molar root formation in young growing rats","volume":"330","author":"Bradaschia-Correa","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1097-0185(20000901)260:1<72::AID-AR80>3.0.CO;2-2","article-title":"Bisphosphonate administration alters subcellular localization of vacuolar-type H+ ATPase and Cathepsin K in osteoclasts during experimental movement of rat molars","volume":"260","author":"Sato","year":"2000","journal-title":"Anat Rec"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB47","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajodo.2005.04.028","article-title":"Ask us: some drugs affect tooth movement","volume":"127","author":"Schwartz","year":"2005","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB48","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1177\/00220345940730081301","article-title":"Effects of topical administration of a bisphosphonate (Risedronate) on orthodontic tooth movements in rats","volume":"73","author":"Adachi","year":"1994","journal-title":"J Dent Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0889-5406(99)70290-8","article-title":"An ultrastructural study of the effects of bisphosphonates administration on osteoclastic bone resorption during relapse of experimentally moved rat molars","volume":"115","author":"Kim","year":"1999","journal-title":"Am J Orthod Dentofacial Orthop"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB50","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ejo\/26.5.469","article-title":"Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats","volume":"26","author":"Liu","year":"2004","journal-title":"Eur J Orthod"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB51","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/00220345960750090501","article-title":"Inhibitory effect of the topical administration of a bisphosphonate (Risedronate) on root resorption incident to orthodontic tooth movement in rats","volume":"75","author":"Igarashi","year":"1996","journal-title":"J Dent Res"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB52","first-page":"425","article-title":"Bisphosphonates and orthodontics: clinical implications","volume":"7","author":"Graham","year":"2006","journal-title":"JCO"},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB53","unstructured":"53.American Dental Association. Report of the Council of Scientific Affairs. Expert panel recommendations: dental management of patients on oral bisphosphonate therapy. Available at: http:\/\/www.ada.org\/prof\/resources\/topics\/osteonecrosis.asp [cited 16 March 2009]."},{"key":"10.1111\/j.1601-6343.2009.01472.x-BIB54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajodo.2006.09.035","article-title":"Bisphosphonate treatment: a present orthodontic concern calling for a proactive approach","volume":"131","author":"Zahrowski","year":"2007","journal-title":"Am J Orthod Dentofacial Orthop"}],"container-title":["Orthodontics &amp; Craniofacial Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-6343.2009.01472.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1601-6343.2009.01472.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T23:06:07Z","timestamp":1625526367000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-6343.2009.01472.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1601-6343.2009.01472.x","relation":{},"ISSN":["1601-6335","1601-6343"],"issn-type":[{"value":"1601-6335","type":"print"},{"value":"1601-6343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}